Prostate Cancer Medicines — Generic Treatments

Prostate cancer is the most common cancer in men, affecting over 1.4 million people annually. When localized disease progresses or becomes castration-resistant, androgen deprivation therapy (ADT) and novel hormone agents are essential. At OnlineMeds, we provide FDA-approved generic prostate cancer medicines at 88–92% savings compared to branded alternatives.

Understanding Prostate Cancer Treatments

Prostate cancer treatment depends on stage, PSA level, and Gleason score:

  • Localized Disease (Gleason ≤6, PSA <10): Active surveillance, surgery, or radiation often sufficient without hormone therapy.
  • Intermediate/High-Risk Disease: Androgen deprivation therapy (GnRH agonists or antagonists) combined with radiation or surgery.
  • Metastatic Castration-Sensitive Prostate Cancer (mCSPC): Immediate ADT plus docetaxel or abiraterone improves survival.
  • Castration-Resistant Prostate Cancer (mCRPC): Novel hormone agents (Abiraterone, Enzalutamide) or chemotherapy (Docetaxel, Cabazitaxel) are used when PSA rises despite castrate testosterone levels.

Available Generic Prostate Cancer Medicines

Browse our full selection of generic prostate cancer treatments at Prostate Cancer Medicines Category:

  • Abiraterone Acetate 250 mg (Zytiga generic) — mCRPC
  • Enzalutamide 40 mg (Xtandi generic) — CRPC
  • Bicalutamide 50 mg (Casodex generic) — ADT adjunct
  • Leuprolide (Lupron generic) — GnRH agonist, ADT
  • Goserelin (Zoladex generic) — GnRH agonist, ADT
  • Degarelix (Firmagon generic) — GnRH antagonist, ADT
  • Docetaxel intravenous (Taxotere generic) — mCRPC chemotherapy

Patient Story

“At age 72, I was diagnosed with metastatic castration-resistant prostate cancer with a PSA of 287. My oncologist prescribed Abiraterone, but the branded Zytiga cost $13,500 per month. Through OnlineMeds, I obtained generic Abiraterone for $680 per month. After 8 months of treatment, my PSA dropped to 4.2, and I’ve extended my life meaningfully while saving over $104,000.” — Robert, Australia

Frequently Asked Questions

1. What is castration-resistant prostate cancer (CRPC)?
CRPC occurs when PSA rises or cancer progresses despite testosterone levels less than 50 ng/dL (achieved through surgical or chemical castration). Novel hormone agents or chemotherapy are then indicated.

2. Is generic Abiraterone as effective as branded Zytiga?
Yes. Generic Abiraterone contains the same active ingredient and achieves identical PSA response rates and overall survival benefits as Zytiga in clinical practice.

3. How long can I stay on Abiraterone or Enzalutamide?
As long as PSA is declining or stable and you tolerate the medication. Many patients continue for months to years. Treatment continues until PSA progression or intolerable side effects develop.

4. What are the side effects of Abiraterone?
Hypertension, hypokalemia (low potassium), fluid retention, and adrenal insufficiency are common. You’ll need regular blood work and blood pressure monitoring. Prednisone is often given to prevent side effects.

5. Can I still have sexual function while on ADT?
ADT significantly decreases testosterone, causing erectile dysfunction and loss of libido. Some men recover sexual function after stopping ADT, while others have permanent changes. Discuss management options with your oncologist.

6. How often do I need PSA testing and monitoring?
Every 4–12 weeks initially, then less frequently once stable. Regular PSA monitoring is essential to assess treatment response and detect progression requiring therapy adjustment.

7. Are there long-term side effects of ADT I should expect?
Yes. Prolonged ADT increases risk of osteoporosis, cardiovascular disease, metabolic syndrome, and cognitive changes. Bone-protective therapy and cardiovascular risk management are often recommended.

Medical Disclaimer

This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed urologic oncologist before starting, stopping, or changing any prostate cancer medication. Prostate cancer is a serious condition requiring specialized care and lifelong monitoring.

OnlineMeds is not a substitute for regular oncology care. Continue appointments with your urologic oncologist to monitor PSA levels, manage side effects, and adjust therapy as needed. If you experience any adverse reactions or unusual symptoms, contact your healthcare provider immediately.

Prescription Required. All prostate cancer medicines are supplied with a valid physician prescription only.